Works matching IS 10781552 AND DT 2020 AND VI 26

Results: 314
    1

    Response of an oncology unit in the midst of the COVID-19 outbreak.

    Published in:
    Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 8, p. 1947, doi. 10.1177/1078155220967973
    By:
    • Liontos, Michalis;
    • Kastritis, Efstathios;
    • Migkou, Magdalini;
    • Koutsoukos, Konstantinos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Gavriatopoulou, Maria;
    • Psaltopoulou, Theodora;
    • Zagouri, Flora;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios Athanasios
    Publication type:
    Article
    2
    3
    4

    Tyrosine kinase inhibitors and COVID-19.

    Published in:
    2020
    By:
    • Semih, Başcı;
    • Tuğçe Nur, Yiğenoğlu;
    • Mehmet Sinan, Dal;
    • Serdal, Korkmaz;
    • Burhan, Turgut;
    • Fevzi, Altuntaş
    Publication type:
    Letter to the Editor
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Tamoxifen-induced acute mania: A case report.

    Published in:
    Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 8, p. 2025, doi. 10.1177/1078155220915959
    By:
    • Duman, Berker;
    • Kuşman, Adnan;
    • Çolak, Burçin;
    • Şenler, Filiz Çay;
    • Kumbasar, Hakan
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34

    The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience.

    Published in:
    Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 8, p. 1857, doi. 10.1177/1078155220905654
    By:
    • Batgi, Hikmettullah;
    • Merdin, Alparslan;
    • Dal, Mehmet Sinan;
    • Kızıl Çakar, Merih;
    • Yıldız, Jale;
    • Başçı, Semih;
    • Uncu Ulu, Bahar;
    • Yiğenoğlu, Tuğçe Nur;
    • Darçın, Tahir;
    • Şahin, Derya;
    • Bakırtaş, Mehmet;
    • Tetik, Ayşegül;
    • İskender, Dicle;
    • Altuntaş, Fevzi
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors.

    Published in:
    Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1676, doi. 10.1177/1078155220953198
    By:
    • Başcı, Semih;
    • Ata, Naim;
    • Altuntaş, Fevzi;
    • Yiğenoğlu, Tuğçe Nur;
    • Dal, Mehmet Sinan;
    • Korkmaz, Serdal;
    • Namdaroğlu, Sinem;
    • Baştürk, Abdülkadir;
    • Hacıbekiroğlu, Tuba;
    • Doğu, Mehmet Hilmi;
    • Berber, İlhami;
    • Dal, Kürşat;
    • Erkurt, Mehmet Ali;
    • Turgut, Burhan;
    • Çağlayan, Murat;
    • Ayvalı, Mustafa Okan;
    • Çelik, Osman;
    • Ülgü, Mustafa Mahir;
    • Birinci, Şuayip
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50